Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus

被引：2

作者：

Arima, Hiroshi ^{[1
,2
,12
]}

Cheetham, Timothy ^{[3
,4
]}

Christ-Crain, Mirjam ^{[5
,6
]}

Cooper, Deborah ^{[7
]}

Gurnell, Mark ^{[6
,8
,9
]}

Drummond, Juliana B. ^{[10
,11
]}

Levy, Miles ^{[12
,13
]}

McCormack, Ann, I ^{[14
,15
]}

Verbalis, Joseph ^{[16
,17
]}

Newell-Price, John ^{[17
,18
]}

Wass, John A. H. ^{[19
,20
]}

机构：

[1] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan

[2] Japan Endocrine Soc, Nagoya, Japan

[3] Newcastle Univ, Great North Childrens Hosp, Royal Victoria Infirm, Dept Paediat Endocrinol,Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England

[4] European Soc Pediat Endocrinol, Bristol, Avon, England

[5] Univ Basel, Univ Hosp Basel, Dept Endocrinol Diabet & Metab, Basel, Switzerland

[6] European Soc Endocrinol, Bristol, Avon, England

[7] Pituitary Fdn, Bristol, Avon, England

[8] Univ Cambridge, Wellcome MRC Inst Metab Sci, Cambridge, England

[9] Addenbrookes Hosp, Cambridge Biomed Campus, Cambridge, England

[10] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil

[11] Brazilian Soc Endocrinol & Metab, Brasilia, DF, Brazil

[12] Univ Hosp Leicester, Endocrinol, Leicester, Leics, England

[13] Soc Endocrinol, Bristol, Avon, England

[14] Garvan Inst Med Res, Hormones & Canc Grp, Sydney, NSW, Australia

[15] Endocrine Soc Australia, Sydney, NSW, Australia

[16] Georgetown Univ, Endocrinol & Metab, Med Ctr, Washington, DC 20057 USA

[17] Endocrine Soc, Washington, DC 20036 USA

[18] Univ Sheffield, Med Sch, Dept Oncol & Metab, Sheffield, S Yorkshire, England

[19] Oxford Ctr Diabet Endocrinol & Metab Endocrinol, Dept Endocrinol, Oxford, England

[20] Pituitary Soc, Stockport, Lancs, England

来源：

ENDOCRINE CONNECTIONS | 2022年 / 11卷 / 11期

关键词：

renaming; diabetes insipidus;

D O I：

10.1530/EC-22-0378

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

'What's in a name? That which we call a rose/By any other name would smell as sweet' (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word, and it therefore represents a convention with no intrinsic meaning. While this may be relevant to romantic literature, disease names do have real meanings, and consequences, in medicine. Hence, there must be a very good rationale for changing the name of a disease that has a centuries-old historical context. A working group of representatives from national and international endocrinology, and pediatric endocrine societies now proposes changing the name of 'diabetes insipidus' to 'arginine vasopressin deficiency (AVP-D)' for central etiologies, and 'arginine vasopressin resistance (AVP-R)' for nephrogenic etiologies. This article provides both the historical context and the rationale for this proposed name change.

引用

页数：4

共 11 条

[1] Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey [J].